Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction

[1]  P. Griffiths,et al.  Definitions of cytomegalovirus infection and disease in transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Boeckh,et al.  Cytomegalovirus pp 65 Antigenemia-Guided Early Treatment With Ganciclovir Versus Ganciclovir at Engraftment After Allogeneic Marrow Transplantation : A Randomized Double-Blind Study , 2002 .

[3]  C. Craddock,et al.  Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. , 2001, Blood.

[4]  A. Limaye,et al.  Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. , 2001, The Journal of infectious diseases.

[5]  S. Mineishi,et al.  Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan , 2001, Bone Marrow Transplantation.

[6]  S. Ogawa,et al.  Real-Time Automated PCR for Early Diagnosis and Monitoring of Cytomegalovirus Infection after Bone Marrow Transplantation , 2000, Journal of Clinical Microbiology.

[7]  C. Sabin,et al.  Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation , 2000, The Lancet.

[8]  F. Baldanti,et al.  Human Cytomegalovirus Immediate-Early mRNA Detection by Nucleic Acid Sequence-Based Amplification as a New Parameter for Preemptive Therapy in Bone Marrow Transplant Recipients , 2000, Journal of Clinical Microbiology.

[9]  A. Caliendo,et al.  Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. , 2000, Journal of clinical microbiology.

[10]  T. Hibi,et al.  Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation , 2000, Bone Marrow Transplantation.

[11]  M. Boeckh,et al.  Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. , 1999, Blood.

[12]  P. Ljungman,et al.  Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. , 1998, Transplantation.

[13]  S. Brunet,et al.  Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience , 1998, Bone Marrow Transplantation.

[14]  Y. Yazaki,et al.  Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation. , 1998, British journal of haematology.

[15]  M. Boeckh,et al.  Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. , 1997, Transplantation.

[16]  L. Verdonck,et al.  A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants. , 1997, Clinical Infectious Diseases.

[17]  K. Takenaka,et al.  Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors , 1997, Bone Marrow Transplantation.

[18]  M. Boeckh,et al.  Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. , 1996, Blood.

[19]  J. Petit,et al.  Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures , 1996, Journal of clinical microbiology.

[20]  H. Einsele,et al.  Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. , 1996, Bone marrow transplantation.

[21]  P. Ljungman,et al.  Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients. , 1996, Bone marrow transplantation.

[22]  D. Michel,et al.  Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples , 1995, Journal of clinical microbiology.

[23]  K. Wittkowski,et al.  Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. , 1995, Blood.

[24]  K. Akashi,et al.  Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV‐associated disease after bone marrow transplantation , 1994, British journal of haematology.

[25]  S. Plotkin,et al.  Multidisciplinary approach to understanding cytomegalovirus disease : proceedings of the Fourth International Cytomegalovirus Workshop: Multidisciplinary Approaches to Understanding CMV Disease, Paris, France, 19-21 April, 1993 , 1993 .

[26]  K. Akashi,et al.  Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease. , 1993, Bone marrow transplantation.

[27]  M. Boeckh,et al.  Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. , 1992, Blood.

[28]  W. V. van Son,et al.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes , 1988, Journal of medical virology.

[29]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[30]  K. Sullivan,et al.  Allogeneic marrow transplantation. , 1984, Cancer investigation.

[31]  H. Stern.  Cytomegalovirus Infection * , 1975, The British journal of clinical practice.

[32]  R Storb,et al.  Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.